Stay updated on 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.

Latest updates to the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMinor system update shows Revision: v3.4.2 replacing v3.4.1; no impact on study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1; this appears to be a minor backend/version update with no changes to the study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange Detected- Footer revision tag updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations data was updated with new site entries across several regions (e.g., Florida, Indiana, Kentucky, New Jersey, New York, etc., plus international regions), and some regional location subsections were removed/reorganized.SummaryDifference2%

- Check91 days agoChange DetectedPublications section text was updated to indicate that publications are automatically filled from PubMed and may not be about the study, changing the previous description that a list is automatically created by ClinicalTrials.gov. This is a cosmetic data-source clarification.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page no longer displays a banner about lapses in government funding and operating status. This notice was a general site-wide message and its removal does not affect the study content or results.SummaryDifference0.2%

Stay in the know with updates to 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.